“…38,40,41 In line with this, several studies have compared a number of hemostatic biomarkers in people with obesity and normal weight. These studies conclude that obesity is accompanied by increased levels of biomarkers of endothelial function, e.g., t-PA:Ag and von Willebrand factor (vWF), [42][43][44][45][46] coagulation, e.g., fibrinogen, FVII, TF, factor IX (FIX), factor X (FX), factor XII (FXII), F1 þ 2, thrombin-AT complexes (TAT), Ddimer, 34,42,44,45,[47][48][49][50][51][52] and impaired fibrinolysis, for example, PAI-1 42,43,45,46,51,53 and TAFI. 54,55 Interestingly, it has been suggested that obesity is accompanied by elevated concentrations of coagulation inhibitors, such as protein C, AT, and TFPI, 38,52,56 perhaps as a protective response toward the increased thrombotic risk in obesity.…”